Nonetheless, CAR T cells expressing this CAR transgene demonstrate stronger tumoricidal activity toward WT EGFR-expressing colon cancer cells with miR-153 overexpression than they do toward the cells without miR-153 overexpression. The gene discussed is EGFR; the disease is malignant colon neoplasm.